• Palmitic acid (Hexadecanoic Acid): Research Protocols & QC G

  2026-07-20

  Palmitic acid (SKU N2456) offers researchers a high-purity, well-characterized saturated long-chain fatty acid suitable for in vitro studies of lipid metabolism, protein palmitoylation, and related signaling pathways. This product is not appropriate for protocols requiring aqueous solubility or long-term solution storage, making precise preparation and immediate use essential for reproducible results.

• Fenofibrate: Age-Independent PPARα-YAP Modulation in Liver R

  2026-07-20

  This thought-leadership article unpacks the mechanistic basis and translational significance of Fenofibrate’s PPARα agonist activity, with a focus on its age-independent effects on liver enlargement via the YAP signaling pathway. Drawing on the latest in vivo evidence, the discussion provides actionable insights for metabolic, aging, and cancer biology researchers, and strategically situates APExBIO’s Fenofibrate (SKU B1943) as a benchmark tool for robust, reproducible experimentation.

• WP1066, JAK2/STAT3 Inhibitor: Precision Tools for Tumor and

  2026-07-19

  Explore how WP1066, a potent JAK2/STAT3 inhibitor, uniquely advances cancer and immune modulation research beyond standard workflows. Gain in-depth insights into mechanistic selectivity, advanced applications, and translational possibilities for renal cell carcinoma and AML studies.

• Caffeic Acid Phenethyl Ester (CAPE): Advanced Bench Workflow

  2026-07-18

  Caffeic Acid Phenethyl Ester (CAPE) is a potent and selective NF-κB inhibitor with proven value in dissecting neuroinflammation and tumor invasion pathways. This article translates cutting-edge findings into practical workflows, highlights troubleshooting strategies, and reveals how CAPE enables targeted modulation of angiogenesis and inflammatory cascades.

• Ibuprofen as an Anti-Proliferative Agent in Colon Cancer Res

  2026-07-17

  Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) is redefining its role in research by offering robust anti-proliferative activity in colon carcinoma models, extending well beyond its function as a non-steroidal anti-inflammatory drug. This guide details optimized workflows, advanced troubleshooting, and cutting-edge applications powered by APExBIO’s high-purity Ibuprofen for reproducible, mechanistic insights.

• Caspase-3 Colorimetric Assay Kit: Precision in Apoptosis Mea

  2026-07-17

  The Caspase-3 Colorimetric Assay Kit by APExBIO transforms apoptosis research by delivering rapid, sensitive, and reproducible DEVD-dependent caspase-3 activity detection. Its streamlined workflow and robust protocol flexibility empower researchers to interrogate immune dynamics, neurodegeneration, and cell death with unmatched confidence.

• Cy5 amine (non-sulfonated): Technical Guide for Biomolecule

  2026-07-16

  Cy5 amine (non-sulfonated) enables efficient covalent labeling of proteins, peptides, and polymers in research workflows where water-insoluble, bright, and photostable dyes are required. It is not suitable for direct aqueous labeling or any diagnostic or clinical use. Strict solvent handling and protocol compliance are essential for high-quality conjugation results.

• Vitamin C Inhibits HEI-OC1 Cell Senescence via ROS/NF-κB Pat

  2026-07-16

  A recent study demonstrates that vitamin C can mitigate D-galactose-induced senescence in cochlear hair cells (HEI-OC1) by suppressing the ROS/NF-κB signaling pathway. These findings provide mechanistic insight into vitamin C's potential as an intervention for age-related hearing loss and support further investigation in cellular aging contexts.

• Hydroxychloroquine Sulfate: Technical Parameters for Autoimm

  2026-07-15

  Hydroxychloroquine Sulfate (SKU B4874) is a synthetic quinoline derivative designed for modulating autophagy and toll-like receptor signaling in autoimmune disease research, particularly in models of systemic lupus erythematosus and rheumatoid arthritis. It is optimal for aqueous-based workflows requiring short-term solution use, but is not suitable for protocols involving organic solvents or long-term solution storage.

• EV-Delivered ACLY Drives TAM Differentiation in Liver Cancer

  2026-07-15

  This study illuminates how hepatocellular carcinoma cells deploy extracellular vesicles to transfer ATP-citrate lyase (ACLY) into monocytes, triggering their differentiation into immunosuppressive tumor-associated macrophages (TAMs). The findings reveal a critical metabolic signaling axis that fuels tumor progression and suggests new therapeutic strategies targeting EV-mediated ACLY transfer to improve immunotherapy outcomes.

• IWP-2: Wnt Production Inhibitor Workflows in Cancer Research

  2026-07-14

  IWP-2, a potent Wnt production inhibitor from APExBIO, enables precise dissection of Wnt/β-catenin signaling in cancer and immunology. This guide reveals advanced workflow enhancements, practical troubleshooting, and actionable insights for robust experimental success.

• ER-Targeted Peptide EISA Selectively Induces Cancer Cell Dea

  2026-07-14

  This study pioneers enzyme-instructed self-assembly (EISA) of ER-targeting peptides that exploit alkaline phosphatase overexpression to selectively induce apoptosis and necroptosis in cancer cells. The innovation lies in precise ER localization, which enhances efficacy and reduces required concentrations, offering a promising direction for organelle-specific cancer therapeutics.

• Ionomycin Calcium Salt: Dissecting Store-Operated Calcium En

  2026-07-13

  Explore the role of Ionomycin calcium salt as a calcium ionophore in modulating intracellular signaling and its unique utility for probing store-operated calcium entry in cancer research. This in-depth analysis highlights critical mechanistic insights and workflow strategies for advanced investigators.

• Efficacy and Resistance of Kitasamycin in Swine Dysentery Co

  2026-07-13

  This study systematically evaluated the efficacy of kitasamycin (leucomycin) for controlling swine dysentery caused by Brachyspira hyodysenteriae in Australian pig herds. It provides evidence for kitasamycin’s potential utility against susceptible isolates, while highlighting the challenge posed by macrolide resistance mutations.

• GW 6471: Precision Antagonism for PPARα Pathway Dissection

  2026-07-12

  Explore how GW 6471, a potent PPARα antagonist from APExBIO, empowers translational researchers to interrogate metabolic and hepatotoxic pathways. This thought-leadership article integrates mechanistic insight, protocol guidance, and strategic foresight, uniquely bridging environmental toxicology and metabolic disease research to shape future innovations in cellular metabolism and lipid homeostasis studies.

15389 records 1/1026 page Next 12345 下5页 Last page